“Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer: An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)

✍ Scribed by E. Engelsman; J.C.M. Klijn; R.D. Rubens; J. Wildiers; L.V.A.M. Beex; M.A. Nooij; N. Rotmensz; R. Sylvester

• Book ID: 119156982
• Publisher: Elsevier Science
• Year: 1991
• Weight: 543 KB
• Volume: 27
• Category: Article
• ISSN: 0277-5379
• DOI: 10.1016/0277-5379(91)90259-g